Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients

Gut

Volumn 55, Issue 4, 2006, Pages 554-562

  McCune, C A ^a   Ravine, D ^b   Carter, K ^c   Jackson, H A ^d   Hutton, D ^e   Hedderich, J ^f   Krawczak, M ^f   Worwood, M ^c  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ROYAL GWENT HOSPITAL   (United Kingdom)

^e Welsh Blood Service   (United Kingdom)

^f UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUROTHYL; IRON; MICROSATELLITE DNA; TRANSFERRIN;

AGED; ARTICLE; BLOOD DONOR; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEATH; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HEMATOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRON DEFICIENCY; IRON OVERLOAD; LIFESTYLE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHENOTYPE; PHLEBOTOMY; POPULATION GENETICS; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPARTATE AMINOTRANSFERASES; CAUSE OF DEATH; FAMILY HEALTH; FEMALE; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHENOTYPE; PHLEBOTOMY; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; SIBLINGS;

EID: 33645121766     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.070342     Document Type: Article

References (57)

1. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
2. The UK Haemochromatosis Consortium, Worwood M. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-4.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
4. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-2.
5. Merryweather-Clarke AT, Cadet E, Bomford A, et al. Diqenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003;12:2241-7.
6. Roetto A, Daraio F, Alberti F, et al. Hemochromatosis due to mutations in transferrin receptor 2. Blood Cells Mol Dis 2002;29:465-70.
7. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-23.
8. Devalia V, Carter K, Walker AP, et al. Autosomol dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002;100:695-7.
9. Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-14.
10. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
11. Distante S, Robson KJH, Graham-Campbell J, et al. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 2004;115:269-79.
12. Witte DL, Crosby WH, Edwards CQ, et al. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
13. Allen K, Williamson R. Screening for hereditary haemochromatosis should be implemented now. BMJ 2000;320:183-4.
14. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
15. Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G → (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-18.
16. McCune CA, Al Jader LN, May A, et al. Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet, 2002;111:538-43.
17. Beutler E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 2003;101:3347-50.
18. Ajioka RS, Kushner JP. Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 2003;101:3351-4.
19. Beutler E. Clinical consequences of iron overload in hemochromatosis homozygotes-Rebuttal to Ajioka and Kushner. Blood 2003;101:3354-7.
20. Ajioka RS, Kushner JP. Clinical consequences of iron overload in hemochromatosis homozygotes-Rebuttal to Beutler. Blood 2003;101:3358.
21. Whitfield JB, Cullen LM, Jazwinska EC, et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000;66:1246-58.
22. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 2000;105:1209-16.
23. Dupic F, Fruchon S, Bensaid M, et al. Duodenal mRNA expression of iron related genes in response to iron loading and iron deficiency in four strains of mice. Gut 2002;51:648-53.
24. Bradley LA, Haddow JE, Palomaki GE. Population screening for hemochromatosis: expectations based on a study of relatives of symptomatic patients. J Med Screen 1996;3:171-7.
25. Bulaj ZJ, Ajioka RS, Phillips JD, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529-35.
26. Fletcher LM, Dixon JL, Purdie DM, et al. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-9.
27. Diwakaran HH, Befeler AS, Britton RS, et al. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J Hepatol 2002;36:687-91.
28. Crawford DHG, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995;57:362-7.
29. Piperno A, Arosio C, Fargion S, et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology 1996;24:43-6.
30. Barton JC, Harmon L, Rivers C, et al. Hemochromatosis: Association of severity of iron overload with genetic markers. Blood Cells Mol Dis 1996;22:195-204.
31. Jackson HA, Carter K, Darke C, et al. HFE mutations, iron deficiency and overload in 10 500 blood donors. Br J Haematol 2001;114:474-84.
32. McCune CA, Ravine D, Worwood M, et al. Screening for hereditary haemochromatosis within families and beyond. Lancet 2003;362:1897-8.
33. Ware JE. Using generic measures of functional health and well-being to increase understanding of disease burden. Spine 2000;25:1467.
34. Worwood M. Iron deficiency anaemia and iron overload. In: Lewis SM, Bain BJ, Bates I, eds. Dacie and Lewis practical haematology. London: Churchill Livingstone, 2001:115-28.
35. Jackson HA, Bowen DJ, Worwood M. Rapid genetic screening for haemochromatosis using heteroduplex technology. Br J Haematol 1997;98:856-9.
36. Worwood M, Jackson HA, Feeney GP, et al. A single tube heteroduplex PCR for the common HFE genotypes. Blood 1999;94:405a.
37. Raha-Chowdhury R, Bowen DJ, Stone C, et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet 1995;4:1869-74.
38. Dooley J, Worwood M. Guidelines on diagnosis and therapy: Genetic haemochromatosis, British Committee for Standards in Haematology. Oxford, Darwin Medical Communications Ltd, 2000 http://www.bcshguidelines.com/pdf/chpt9B.pdf.
39. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
40. Adams PC, Walker AP, Acton RT. A primer for predicting risk of disease in HFE-linked hemochromatosis. Genet Test 2001;5:311-16.
41. Best LG, Harris PE, Spriggs EL. Hemochromatosis mutations C282Y and H63D in 'cis' phase. Clin Genet 2001;60:68-72.
42. Thorstensen K, Asberg A, Kvitland M, et al. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis. Genet Test 2000;4:371-6.
43. Garry PJ, Koehler KM, Simon TL. Iron stores and iron absorption: Effects of repeated blood donations. Am J Clin Nutr 1995;62:611-20.
44. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-62.
45. Crawfotd DHG, Jazwinska EC, Cullen LM, et al. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
46. de Juan MD, Reta A, Castiella A, et al. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 2001;9:961-4.
47. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
48. Ryan E, Byrnes V, Coughlan B, et al. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut 2002;51:108-12.
49. Willis G, Wimperis JZ, Lonsdale R, et al. Haemochromatosis gene mutation in hepatocellular cancer. Lancet 1997;350:565-6.
50. Willis G, Wimperis JZ, Lonsdale R, et al. Incidence of liver disease in people with HFE mutations. Gut 2000;46:401-4.
51. Worwood M. HFE mutations a risk factors for disease. Best Pract Res Clin Haematol 2002;15:295-314.
52. Emery J, Rose P, Harcourt J, et al. Hereditary haemochromatosis: pilot study of case-finding approach to early diagnosis in primary care. Am J Hum Genet 2001;69:1455.
53. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.
54. EASL International Consensus Conference on Haemochromatosis. Co-sponsored by the World Health Organization. Supported by the National Institutes of Health and Centers for Disease Control and Prevention (USA). J Hepatol 2000;33:485-504.
55. Distante S. Phenotypic expression of the HFE gene mutation (C282Y) among the hospitalised population. Gut 2000;47:575-9.
56. Pietrangelo A. Medical progress-hereditary hemochromatosis-A new look at an old disease. N Engl J Med 2004;350:2383-97.
57. Barton JC, Wiener HW, Acton RT, et al. HLA haplotype A*03- B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 2005;34:38-47.